Observational Study of How Patients Take Eye Drops
NCT00750646 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2008-09-10
Summary
This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.
Conditions
Interventions
- DEVICE
-
MEMS cap
The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.
Sponsors & Collaborators
-
Alcon Research
collaborator INDUSTRY -
Robin, Alan L., M.D.
lead INDIV
Principal Investigators
-
Jennifer L Stone, OD · Glaucoma Experts
-
Alan L Robin, MD · Glaucoma Specialists
-
Colleen K Protzko · Glaucoma Specialists
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2009-03-31
- Completion
- 2009-08-31
Countries
- United States
Study Locations
More Related Trials
-
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
NCT04412096 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
NCT00567411 ·Status: UNKNOWN ·Phase: NA
-
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
NCT00047541 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00761709 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a Glaucoma Drug Delivery System
NCT00824720 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
NCT00047515 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence Improvement in Glaucoma Patients
NCT00603005 ·Status: COMPLETED ·Phase: NA
-
24-hour IOP-lowering Effect of 0.01% Bimatoprost
NCT01271686 ·Status: COMPLETED ·Phase: PHASE4
-
Real-time Glaucoma Medication Adherence
NCT03194828 ·Status: TERMINATED ·Phase: NA
-
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
NCT01312454 ·Status: TERMINATED ·Phase: PHASE2
-
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT00051194 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a Drug Delivery System in Glaucoma
NCT01016691 ·Status: COMPLETED ·Phase: PHASE2
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
NCT05844384 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
NCT01426464 ·Status: UNKNOWN ·Phase: PHASE2
-
Glaucoma Adherence Study
NCT00676637 ·Status: COMPLETED
-
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT05456724 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
NCT02003547 ·Status: COMPLETED ·Phase: PHASE1
-
Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
NCT02656394 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Preference Study
NCT00576342 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00069719 ·Status: COMPLETED ·Phase: PHASE2
-
Glaucoma Drop Aids Part 2
NCT06806332 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
NCT01687426 ·Status: COMPLETED ·Phase: PHASE1
-
24-hour IOP-lowering Effect of Brimonidine 0.1%
NCT00457795 ·Status: COMPLETED ·Phase: PHASE4
-
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00691717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3